Oruka Therapeutics, Inc. (ORKA) vs PTC Therapeutics, Inc. (PTCT)
- Oruka Therapeutics, Inc. ORKA 71.93 −2.63%
- PTC Therapeutics, Inc. PTCT 59.24 −2.87%
Oruka Therapeutics, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Oruka Therapeutics, Inc. and PTC Therapeutics, Inc. are of similar size ($5.1B and $4.9B). Oruka Therapeutics, Inc. has the higher net margin (0.00% vs −3.80%) and the lower return on invested capital (−40.2% vs 15.2%). Across the 13 metrics below, PTC Therapeutics, Inc. leads on 9 and Oruka Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ORKA | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 92.99% | 65.16% |
| Operating margin | 0.00% | 12.45% | 0.00% |
| Net margin | 0.00% | (3.80%) | 0.00% |
| Free cash flow margin | 0.00% | (29.76%) | 0.00% |
| Return on equity | (18.30%) | 20.64% | (56.36%) |
| Return on assets | (17.76%) | (1.30%) | (48.04%) |
| Return on invested capital | (40.22%) | 15.16% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack